Environmental chemical-induced pro/pre-B cell apoptosis: Analysis of c-Myc, p27Kip1, and p21WAF1 reveals a death pathway distinct from clonal deletion

Journal of Immunology

Volumn 170, Issue 10, 2003, Pages 4897-4904

  Ryu, Heui Young ^a   Mann, Koren K ^a   Schlezinger, Jennifer J ^a   Jensen, Brenda ^a   Sherr, David H ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DEXAMETHASONE; DIMETHYLBENZ[A]ANTHRACENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0037651104     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.10.4897     Document Type: Article

References (55)

1. 1 growth arrest of murine B-cell lymphomas. Mol. Biol. Cell 7:553.
2. Scott, D. W., J. Tuttle, D. Livnat, W. Haynes, J. P. Cogswell, and P. Keng. 1985. Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-μ of WEHI-231 and the selection and properties of resistant mutants. Cell. Immunol. 93:124.
3. Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of c-myc expression induces apoptosis of WEHI-231 murine B cells. Mol. Cell. Biol. 16:5015.
4. Wu, M., M. Arsura, H. Lee, S. Schauer, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:101.
5. Kip1. Eur. J. Immunol. 30:1154.
6. Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI-231 B cells. J. Immunol. 163:6530.
7. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688.
8. WAF1/CIP1 in receptor-mediated apoptosis of WEHI-231 B lymphoma cells. J. Exp. Med. 187:1671.
9. Styczynski, J., R. Pieters, D. R. Huismans, G. J. Schuurhuis, M. Wysocki, and A. J. Veerman. 2000. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br. J. Haematol. 110:813.
10. Longui, C. A., A. Vottero, P. C. Adamson, D. E. Cole, T. Kino, O. Monte, and G. P. Chrousos. 2000. Low glucocorticoid receptor α/β ratio in T-cell lymphoblastic leukemia. Horm. Metab. Res. 32:401.
11. Andreau, K., C. Lemaire, V. Souvannavong, and A. Adam. 1998. Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology 40:67.
12. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakaya. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.
13. + peritoneal B lymphocyte populations. Cell. Immunol. 161:50.
14. Kincade, P. W., G. Lee, C. E. Pietrangeli, S.-I. Hayashi, and J. M. Gimble. 1989. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu. Rev. Immunol. 7:111.
15. Yamaguchi, K., R. I. Near, R. A. Matulka, A. Shneider, P. Toselli, A. F. Trombino, and D. H. Sherr. 1997. Activation of the aryl hydrocarbon receptor/transcription factor and stromal cell-dependent pre-B cell apoptosis. J. Immunol. 158:2165.
16. Yamaguchi, K., R. A. Matulka, A. Shneider, P. Toselli, A. F. Trombino, S. Yang, L. J. Hafer, K. K. Mann, X.-J. Tao, J. L. Tilly, et al. 1997. Induction of pre-B cell apoptosis by 7,12-dimethyl[a]benzanthracene in long term bone marrow cultures. Toxicol. Appl. Pharmacol. 147:190.
17. Quadri, S., A. Qadri, K. L. Mann, and D. H. Sherr. 2000. The bioflavonoid galangin blocks aryl hydrocarbon receptor (AhR) activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis. Mol. Pharmacol. 58:515.
18. Near, R. I., K. K. Mann, R. A. Matulka, A. M. Shneider, S. U. Gogate, A. F. Trombino, and D. H. Sherr. 1999. Regulation of pre-B cell apoptosis by aryl hydrocarbon receptor/transcription factor-expressing stromal/adherent cells. Proc. Soc. Exp. Biol. Med. 221:242.
19. Mann, K. K, S. Doerre, D. H. Sherr, and S. Quadri. 2001. The role of NF-κB as a survival factor in environmental chemical-induced pre-B cell apoptosis. Mol. Pharmacol. 59:302.
20. Mann, K. K., R. A. Matulka, B. P. Lawrence, N. I. Kerkvliet, and D. H. Sherr. 1999. The role of cytochrome P-450 enzymes in 7,12-dimethylbenzanthracene-induced apoptosis. Toxicol. Appl. Pharmacol. 161:10.
21. Dean, J. H., M. I. Luster, G. A. Boorman, L. D. Lauer, R. W. Luebke, and L. D. Lawson. 1983. Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice. Clin. Exp. Immunol. 52:199.
22. Thurmond, L. M., R. V. House, L. D. Lauer, and J. H. Dean. 1988. Suppression of splenic lymphocyte function by 7,12-dimethylbenz anthracene in murine lymphoid cells. Toxicol. Appl. Pharmacol. 93:369.
23. Thurmond, L., L. Lauer, R. House, J. Cook, and J. Dean. 1987. Immunosuppression following exposure to 7,12-dimethylbenz anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice. Toxicol. Appl. Pharmacol. 91:450.
24. Shepherd, D. M., L. B. Steppan, O. R. Hedstrom, and N. I. Kerkvliet. 2001. Anti-CD40 treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57BL/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity. Toxicol. Appl. Pharmacol. 170:10.
25. Vorderstrasse, B. A., and N. I. Kerkvliet. 2001. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol. Appl. Pharmacol. 171:117.
26. Heidel, S. M., P. S. MacWilliams. W. M. Baird, W. M. Dashwood, J. T. Buters, F. J. Gonzalez, M. C. Larsen, C. J. Czuprynski, and C. R. Jefcoate. 2000. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz anthracene. Cancer Res. 60:3454.
27. Holladay, S. D., and B. J. Smith. 1995. Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene. Environ. Res. 68:106.
28. Holladay, S. D., and B. J. Smith. 1995. Benzo[a]pyrene-induced alterations in total immune cell number and cell-surface antigen expression in the thymus, spleen and bone marrow of B6C3F1 mice. Vet. Hum. Toxicol. 37:99.
29. Silverstone, A. E., J. D. E. Frazier, N. C. Fiore, J. A. Soults, and T. A. Gasciewicz. 1994. Dexamethsaone, β-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 126:248.
30. Hardin, J. A., F. Hinoshita, and D. H. Sherr. 1992. Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol Appl. Pharmacol. 117:155
31. Matikainen, T., G. I. Perez, A. Jurisicova, K. K. Mann, J. J. Schlezinger, H.-Y. Ryu, T. Sakai. S. J. Korsmeyer, R. F. Casper, D. H. Sherr, and J. T. Tilly. 2001. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat. Genet. 28:1.
32. Kip1 accumulation in murine B-lymphoma cells: role of c-Myc and calcium. Cell Growth Differ. 10:695.
33. Holladay, S. D., and B. J. Smith. 1994. Fetal hematopoietic alterations after maternal exposure to benzo[a]pyrene: a cytometric evaluation. J. Toxicol. Environ. Health 42:259.
34. Holladay, S. D., and M. I. Luster. 1996. Alterations in fetal thymic and liver hematopoietic cells as indicators of exposure to developmental immunotoxicants. Environ. Health Perspect. 104:809.
35. Jacobsen, K., V. Prasad, C. Sidman, and D. Osmond. 1994. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of Em-myc transgenic mice. Blood 84:2784.
36. FitzGerald, M. J., M. Arsura, R. E. Bellas, W. Yang, M. Wu, L. Chin, K. K. Mann, R. A. DePinho, and G. E. Sonenshein. 1999. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc. Oncogene 18:2489.
37. Leonetti, C., I. D'Agnano, F. Lozupone, A. Valentini, T. Geiser, G. Zon, B. Calabretta, G. C. Citro, and G. Zupi. 1996. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. J. Natl. Cancer Inst. 88:419.
38. Dean, M., J. Cleveland, H. Y. Kim, J. Campisi, R. A. Levine, J. N. Ihle, and U. Rapp. 1988. Deregulation of the c-myc and N-myc genes in transformed cells. Curr. Top. Microbiol. Immunol. 141:216.
39. Janicek, M. F., B. U. Sevin, H. N. Nguyen, and H. E. Averette. 1995. Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines. Gynecol. Oncol. 59:87.
40. Kaptein, J. S., C. K. Lin, C. L. Wang, T. T. Nguyen, C. I. Kalunta, E. Park, F. S. Chen, and P. M. Lad. 1996. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis. J. Biol. Chem. 271:18875.
41. Thulasi, R., D. V. Harbour, and E. B. Thompson. 1993. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J. Biol. Chem. 268:18306.
42. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571.
43. KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene 18:1663.
44. Kip1. J. Clin. Invest. 103:597.
45. Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 18:1411.
46. KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis. Oncogene 19:3115.
47. Kim, S. G. S. N. Kim, H. S. Jong, N. K. Kim, S. H. Hong, S. J. Kim, and Y. J. Bang. 2001. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-β1-induced apoptosis in human gastric cancer cells. Oncogene 20:1254.
48. Kip1 mediates its anti-apoptotic activity. Oncogene 18:4839.
49. Nitta, T., K. Igarashi, and N. Yamamoto. 2002. Polyamine depletion induces apoptosis through mitochondria-mediated pathway. Exp. Cell Res. 276:120.
50. Zou, C., A. T. Vlastos, L. Yang, J. Wang, K. Nishioka, and M. Follen. 2002. Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines. Gynecol. Oncol. 85:266.
51. Miller, A. L., B. H. Johnson, R. D. Medh, C. M. Townsend, and E. B. Thompson. 2002. Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells. Neoplasia 4:68.
52. Magnet, K. J., M. S. Orr, J. L. Cleveland, C. Rodriguez-Galindo, H. Yang, C. Yang, Y. M. Di, P. T. Jain, and D. A. Gewirtz. 2001. Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells. Biochem. Pharmacol. 62:593.
53. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1:553.
54. Heidel, S. M., K. Holston, J. T. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski. 1999. Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol. 56:1317.
55. Corroyer, S., E. Nabeyrat, and A. Clement. 1997. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Endocrinology 138:3677.